1 / 15

Continuing Medical Education (CME)

Continuing Medical Education (CME). Disclaimer Planning Committee members have no financial relationships to disclose Presenter(s) has/have no financial relationships to disclose. The Role of Speech Language Pathology in Neurodegenerative Diseases. Presented by: Amy Taylor, MS, CCC-SLP/L.

pernst
Download Presentation

Continuing Medical Education (CME)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Continuing Medical Education (CME) DisclaimerPlanning Committee members have no financial relationships to disclose Presenter(s) has/have no financial relationships to disclose.

  2. The Role of Speech Language Pathologyin Neurodegenerative Diseases Presented by: Amy Taylor, MS, CCC-SLP/L March 12, 2016

  3. Speech Language Pathology Amy Taylor, M.S., CCC-SLP Outpatient Speech Language Pathologist St. Luke’s North

  4. Objectives • Understand the reasons to refer to an SLP • Identify the SLP assessment methods for dysphagia and communication impairments • Identify types of AAC candidates and devices

  5. Speech Language Pathology Refer to an SLP for the following concerns: • Swallowing or eating difficulties • Difficulty communicating • Difficulty being understood • Word finding problems • Memory and cognition deficits • Voice Changes

  6. Speech Language Pathology Evaluation and diagnosis • Dysphagia • Communication Impairments Following the evaluation, recommendations and an individual treatment plan is developed

  7. Dysphagia in Neurodegenerative Disease • As many as 57% of patients with NDD will be impacted by Dysphagia. • Variable presentations by diagnosis • Early detection helps prevent dehydration, malnutrition, weight loss, and aspiration pneumonia • (Walshe, et al., 2014).

  8. Dysphagia • What can an SLP do for dysphagia? • Assess the patient’s risk for aspiration and possible dysphagia • Clinical Evaluation of Swallowing • Modified Barium Swallow Studies • FEES • Recommend strategies of diet modification or meal time strategies for safe swallowing • Implement therapy • Compensatory or rehabilitative • Exercise • Specialized therapy techniques • Neuromuscular Electrical Stimulation (NMES)

  9. Communication deficitsin Neurodegenerative Disease May present as: • Motor Speech Disorders • Apraxia • Dysarthria • Aphasia • Cognitive-linguistic deficits • Voice Disorders • Any combination of the above

  10. Assessment of Communication • General assessment categories • Apraxia • VisiPitch Motor Speech Profile • Informal speech tasks • Informal and audiotory - perceptual judgement • Dysarthria • Assessment of Intelligibility of Dysarthric Speech • Frenchay • VisiPitch Motor Speech Profiles • Informal and audiotory - perceptual judgement • Aphasia • Boston Diagnostic Aphasia Examination • Boston Assessment of Severe Aphasia • Western Aphasia Battery • Boston Naming Test • Cognitive-linguistic deficits • Assessment Battery of Communication for Dementia • Cognitive Linguistic Quick Test • Ross Information Processing Test • Voice Disorders • VisiPitch • Sound Level Meter

  11. Speech Therapy for Communication • Develop an individual treatment plan • Rehabilitation • Strategies • Alternatives • Education

  12. Augmentative Alternative Communication (AAC) • What is AAC and who are candidates? • Basic • Low tech • High tech • How do we assess? • Language assessment results • Screening for candidate • Consider all factors • What happens next? • Recommend device for alternative communication device • Intervention

  13. References • Journal of Gastroenterology and Hepatology Research. Oropharyngeal Dysphagia in Neurodegenerative Disease.Margaret Walshe, Accepted: July 12, 2014 Image retrieved from 111.ghret.org/index.php/joghr/article/view/883/1012 on January 19, 2016 • The ASHA Leader, November 2008, Vol. 13, 10-13. Motor Speech Disorders and the Diagnosis of Neurologic Disease: Still a Well-kept Secret? Joseph R. Duffy, PhD, CCC-SLP • Medscape Reference. Aphasia Clinical Presentation Howard S Kirshner, MD; Chief Editor: Michael Hoffmann, MBBCh, MD  more...Image retrieved from emedicine.medscape.com/article/1135944-clinical#b5 on January 21/2016 • Julie Barkmeier-Kraemer, MA, PhD, CCC-SLP asha.org, http://www.asha.org/Events/Neurodegenerative-Disorders/Session-Descriptions/ 2016 • Bayles,Kathryn and Tomoeda, Cheryl Cognitive-Communication Disorders of Dementia. 2013 Plural Publishing • NeuroRehabilitation (2015). Supporting communication for patients with neurodegenerative disease. Image retreived from www.ncbi.nlm.nih.gov/pubmed/26409694

  14. Questions?

  15. Where can you find us? St Luke’s North 153 Brodhead Road Bethlehem PA 18017 610-954-3200

More Related